title: Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community.
abstract: During the last 2 decades, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains have dramatically increased the global burden of S. aureus infections. The pandemic sequence type (ST)8/pulsed-field gel type USA300 is the dominant CA-MRSA clone in the United States, but its evolutionary history and basis for biological success are incompletely understood. Here, we use whole-genome sequencing of 387 ST8 isolates drawn from an epidemiological network of CA-MRSA infections and colonizations in northern Manhattan to explore short-term evolution and transmission patterns. Phylogenetic analysis predicted that USA300 diverged from a most common recent ancestor around 1993. We found evidence for multiple introductions of USA300 and reconstructed the phylogeographic spread of isolates across neighborhoods. Using pair-wise single-nucleotide polymorphism distances as a measure of genetic relatedness between isolates, we observed that most USA300 isolates had become endemic in households, indicating their critical role as reservoirs for transmission and diversification. Using the maximum single-nucleotide polymorphism variability of isolates from within households as a threshold, we identified several possible transmission networks beyond households. Our study also revealed the evolution of a fluoroquinolone-resistant subpopulation in the mid-1990s and its subsequent expansion at a time of high-frequency outpatient antibiotic use. This high-resolution phylogenetic analysis of ST8 has documented the genomic changes associated with USA300 evolution and how some of its recent evolution has been shaped by antibiotic use. By integrating whole-genome sequencing with detailed epidemiological analyses, our study provides an important framework for delineating the full diversity and spread of USA300 and other emerging pathogens in large urban community populations.
authors.affiliation: Department of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, NY 10032.
authors.forename: Anne-Catrin
authors.initials: AC
authors.lastname: Uhlemann
authors.forename: Janina
authors.initials: J
authors.lastname: Dordel
authors.forename: Justin R
authors.initials: JR
authors.lastname: Knox
authors.forename: Kathy E
authors.initials: KE
authors.lastname: Raven
authors.forename: Julian
authors.initials: J
authors.lastname: Parkhill
authors.forename: Matthew T G
authors.initials: MT
authors.lastname: Holden
authors.forename: Sharon J
authors.initials: SJ
authors.lastname: Peacock
authors.forename: Franklin D
authors.initials: FD
authors.lastname: Lowy
mesh_terms: D016022:Case-Control Studies; D017714:Community-Acquired Infections / Q000453:epidemiology / Q000382:microbiology / Q000635:transmission; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D019143:Evolution, Molecular; D016680:Genome, Bacterial; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000145:classification / Q000235:genetics* / Q000302:isolation & purification; D017720:Molecular Epidemiology; D009519:New York City / Q000453:epidemiology; D010802:Phylogeny; D020641:Polymorphism, Single Nucleotide; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology* / Q000635:transmission; D014481:United States / Q000453:epidemiology; D014505:Urban Population
keywords: CC8; drug resistance; genomics; phylogeny
references.citation: Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5796-800
references.pmid: 8516330
references.citation: Bioinformatics. 2005 Aug 15;21(16):3422-3
references.pmid: 15976072
references.citation: Sci Rep. 2013;3:1902
references.pmid: 23712667
references.citation: Bioinformatics. 2005 Feb 15;21(4):456-63
references.pmid: 15608047
references.citation: Lancet. 2006 Mar 4;367(9512):731-9
references.pmid: 16517273
references.citation: JAMA Intern Med. 2013 Aug 12;173(15):1397-404
references.pmid: 23857503
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5883-8
references.pmid: 19293374
references.citation: Antimicrob Agents Chemother. 2011 Aug;55(8):3932-5
references.pmid: 21646488
references.citation: PLoS One. 2013 May 01;8(5):e61319
references.pmid: 23658690
references.citation: Genome Biol Evol. 2012;4(12):1275-85
references.pmid: 23104992
references.citation: Clin Microbiol Infect. 2010 Sep;16(9):1427-34
references.pmid: 20041904
references.citation: Mol Microbiol. 2011 Oct;82(1):9-20
references.pmid: 21902734
references.citation: Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9107-12
references.pmid: 22586109
references.citation: BMC Genomics. 2012 Sep 25;13:508
references.pmid: 23009684
references.citation: Genome Res. 2011 Jun;21(6):961-73
references.pmid: 20980555
references.citation: N Engl J Med. 2005 Apr 7;352(14):1436-44
references.pmid: 15814879
references.citation: Genome Res. 2013 Apr;23(4):653-64
references.pmid: 23299977
references.citation: PLoS One. 2012;7(11):e49900
references.pmid: 23152934
references.citation: J Antimicrob Chemother. 2012 Oct;67(10):2514-22
references.pmid: 22761331
references.citation: N Engl J Med. 2011 Feb 24;364(8):730-9
references.pmid: 21345102
references.citation: Mol Biol Evol. 2013 Feb;30(2):239-43
references.pmid: 23090976
references.citation: J Clin Microbiol. 2003 Nov;41(11):5113-20
references.pmid: 14605147
references.citation: Bioinformatics. 2005 Jun;21 Suppl 1:i351-8
references.pmid: 15961478
references.citation: PLoS One. 2011;6(7):e22407
references.pmid: 21818321
references.citation: Clin Infect Dis. 2006 Mar 1;42(5):647-56
references.pmid: 16447110
references.citation: Mol Biol Evol. 2012 Aug;29(8):1969-73
references.pmid: 22367748
references.citation: Lancet Infect Dis. 2013 Feb;13(2):130-6
references.pmid: 23158674
references.citation: N Engl J Med. 2006 Aug 17;355(7):666-74
references.pmid: 16914702
references.citation: J Clin Microbiol. 2013 Feb;51(2):611-4
references.pmid: 23175259
references.citation: Genome Res. 2008 May;18(5):821-9
references.pmid: 18349386
references.citation: Clin Infect Dis. 2011 Jul 15;53(2):144-9
references.pmid: 21690621
references.citation: BMC Microbiol. 2007 Nov 06;7:99
references.pmid: 17986343
references.citation: J Clin Microbiol. 2010 Dec;48(12):4504-11
references.pmid: 20943864
references.citation: JAMA. 2012 Jul 4;308(1):50-9
references.pmid: 22760291
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1327-32
references.pmid: 18216255
references.citation: Antimicrob Agents Chemother. 2010 Sep;54(9):3804-11
references.pmid: 20585117
references.citation: Clin Microbiol Rev. 2010 Jul;23(3):616-87
references.pmid: 20610826
references.citation: Ann Intern Med. 2008 Feb 19;148(4):249-57
references.pmid: 18283202
references.citation: Protein Sci. 2007 Oct;16(10):2301-5
references.pmid: 17893367
references.citation: J Antimicrob Chemother. 2007 Jul;60(1):42-8
references.pmid: 17468509
references.citation: J Bacteriol. 2009 Jun;191(11):3462-8
references.pmid: 19329640
references.citation: PLoS One. 2012;7(8):e43902
references.pmid: 22952804
references.citation: Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):18091-6
references.pmid: 22025717
references.citation: Cell Host Microbe. 2013 Jan 16;13(1):100-7
references.pmid: 23332159
references.citation: J Infect Dis. 2010 Dec 15;202(12):1866-76
references.pmid: 21050125
references.citation: Science. 2011 Jan 28;331(6016):430-4
references.pmid: 21273480
references.citation: Science. 2010 Jan 22;327(5964):469-74
references.pmid: 20093474
references.citation: Mol Biol Evol. 2012 Sep;29(9):2157-67
references.pmid: 22403239